SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899866-19-000091
Filing Date
2019-09-17
Accepted
2019-09-17 16:12:29
Documents
14
Period of Report
2019-09-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a8-k09172019.htm   iXBRL 8-K 41125
  Complete submission text file 0000899866-19-000091.txt   171506

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxn-20190917.xsd EX-101.SCH 4453
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alxn-20190917_cal.xml EX-101.CAL 639
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alxn-20190917_def.xml EX-101.DEF 1489
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxn-20190917_lab.xml EX-101.LAB 23061
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxn-20190917_pre.xml EX-101.PRE 12071
10 EXTRACTED XBRL INSTANCE DOCUMENT a8-k09172019_htm.xml XML 3781
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 191097267
SIC: 2834 Pharmaceutical Preparations